ATE215934T1 - Neue histidinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel gegen freie radikale - Google Patents

Neue histidinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel gegen freie radikale

Info

Publication number
ATE215934T1
ATE215934T1 AT97912295T AT97912295T ATE215934T1 AT E215934 T1 ATE215934 T1 AT E215934T1 AT 97912295 T AT97912295 T AT 97912295T AT 97912295 T AT97912295 T AT 97912295T AT E215934 T1 ATE215934 T1 AT E215934T1
Authority
AT
Austria
Prior art keywords
histide
derivatives
new
production
free radical
Prior art date
Application number
AT97912295T
Other languages
English (en)
Inventor
Michel Philippe
Thierry Bordier
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE215934T1 publication Critical patent/ATE215934T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97912295T 1996-12-04 1997-10-31 Neue histidinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel gegen freie radikale ATE215934T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614880A FR2756565B1 (fr) 1996-12-04 1996-12-04 Nouveaux derives d'histidine et leur utilisation en cosmetique ou en pharmacie
PCT/FR1997/001957 WO1998024770A1 (fr) 1996-12-04 1997-10-31 Nouveaux derives d'histidine, procede de preparation et leur utilisation comme agents anti-radicaux libres

Publications (1)

Publication Number Publication Date
ATE215934T1 true ATE215934T1 (de) 2002-04-15

Family

ID=9498325

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97912295T ATE215934T1 (de) 1996-12-04 1997-10-31 Neue histidinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel gegen freie radikale

Country Status (10)

Country Link
US (2) US6255344B1 (de)
EP (1) EP0946516B1 (de)
JP (1) JP3233644B2 (de)
AT (1) ATE215934T1 (de)
AU (1) AU4953997A (de)
CA (1) CA2273989C (de)
DE (1) DE69711920T2 (de)
ES (1) ES2175371T3 (de)
FR (1) FR2756565B1 (de)
WO (1) WO1998024770A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756565B1 (fr) * 1996-12-04 1998-12-31 Oreal Nouveaux derives d'histidine et leur utilisation en cosmetique ou en pharmacie
FR2779060B1 (fr) * 1998-05-26 2003-05-02 Oreal Association d'un retinoide avec un derive d'histidine
DE10207177A1 (de) * 2002-02-19 2003-09-04 Novosom Ag Fakultativ kationische Lipide
US6793193B2 (en) * 2002-08-20 2004-09-21 Dart Industries Inc. Adjustable mold for forming shaped food
US7420071B2 (en) * 2005-05-04 2008-09-02 Uchicago Argonne, Llc Thermally stable surfactants and compositions and methods of use thereof
SG11201506069RA (en) 2013-03-13 2015-09-29 Neocutis Sa Peptides for skin rejuvenation and methods of using the same
CN114891060B (zh) * 2022-07-13 2022-09-30 深圳湾实验室 关于蛋白质的光激活依赖性邻近标记方法及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57108072A (en) 1980-12-18 1982-07-05 Ajinomoto Co Inc Preparation of n-acylcarnosine
US4508728A (en) * 1984-05-24 1985-04-02 Kineshiro Nagai Method of treating inflammatory diseases
EP0436611A4 (en) * 1988-09-28 1992-03-11 Peptide Technology Ltd Compound and method for the retardation of collagen cross-linking
FR2661331A1 (fr) 1990-04-30 1991-10-31 Oreal Composition cosmetique ou dermopharmaceutique contenant des vesicules formees par un melange phospholipides/glycolipides.
FR2668365B1 (fr) * 1990-10-25 1994-12-23 Sederma Sa Utilisation en cosmetique des n-acetylpeptides dotes d'une activite biologique.
JP3008131B2 (ja) 1990-11-14 2000-02-14 ロレアル グリセリンから誘導される非イオン両親媒性化合物、その調製方法、相応する中間体化合物及び前記化合物を含有する組成物
EP0571390B1 (de) 1990-11-23 2000-03-08 Peptech Limited Verzögerung, verhinderung und/oder rückgängigmachen von zellalterung
DE69225631T2 (de) * 1991-02-19 1998-12-17 Cci Corp., Gifu Acylaminosäure-Verbindungen und Verfahren zu ihrer Herstellung
FR2680373B1 (fr) 1991-08-12 1995-06-09 Bio Initiatives Procede de synthese enzymatique d'alpha-glucosides, alpha-glucosides ainsi obtenus, et utilisation de ces produits dans l'industrie cosmetique, pharmaceutique, agroalimentaire et chimique.
JP3154789B2 (ja) 1992-03-11 2001-04-09 ローム株式会社 サーマルヘッド駆動回路及びサーマルヘッド
FR2756565B1 (fr) * 1996-12-04 1998-12-31 Oreal Nouveaux derives d'histidine et leur utilisation en cosmetique ou en pharmacie
FR2778917B1 (fr) * 1998-05-25 2000-06-30 Oreal Nouveaux derives d'histidine, procede de preparation et utilisations
FR2779060B1 (fr) * 1998-05-26 2003-05-02 Oreal Association d'un retinoide avec un derive d'histidine

Also Published As

Publication number Publication date
FR2756565B1 (fr) 1998-12-31
US6562789B2 (en) 2003-05-13
EP0946516B1 (de) 2002-04-10
US20010031732A1 (en) 2001-10-18
CA2273989C (fr) 2003-10-21
ES2175371T3 (es) 2002-11-16
JP3233644B2 (ja) 2001-11-26
WO1998024770A1 (fr) 1998-06-11
FR2756565A1 (fr) 1998-06-05
JP2000505813A (ja) 2000-05-16
US20020165165A9 (en) 2002-11-07
DE69711920T2 (de) 2002-08-08
US6255344B1 (en) 2001-07-03
EP0946516A1 (de) 1999-10-06
CA2273989A1 (fr) 1998-06-11
DE69711920D1 (de) 2002-05-16
AU4953997A (en) 1998-06-29

Similar Documents

Publication Publication Date Title
DE69100079D1 (de) Naphthalin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE69416501D1 (de) 2-propylvaleriansäure und 2-propylvalerian-säureamid-derivate und deren verwendung als antikonvulsive mittel
DE69329386D1 (de) Substituierte benzylaminoquinuclidine als substanz p antagonisten
ATE153022T1 (de) 3',5'-ditertbutyl-4'-hydroxyflavone, verfahren zu ihrer herstellung und pharmazeutische zusammensetzung mit antioxidations- und antivasokonstriktionsaktivität
AU7801291A (en) Tinctorial composition based on 5,6-dihydroxyindolines and method for dyeing keratinous fibres
ATE211474T1 (de) Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente
DE3670081D1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
MXPA03000547A (es) Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares.
ATE18549T1 (de) 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
DE3575715D1 (de) Adamantanamin-derivate, verfahren zur herstellung und diese enthaltende heilmittel.
ATE122042T1 (de) Pyrazoloisoquinoline-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE215934T1 (de) Neue histidinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel gegen freie radikale
KR890014480A (ko) 2-피리딜아세트산 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
KR910000711A (ko) 크로만 유도체
EA200001107A1 (ru) ПРОИЗВОДНЫЕ ОКТАГИДРО-6,10-ДИОКСО-6H-ПИРИДАЗИНО [1,2-a] [1,2] ДИАЗЕПИН-1-КАРБОНОВОЙ КИСЛОТЫ, СПОСОБ ПОЛУЧЕНИЯ И ИХ ПРИМЕНЕНИЕ ДЛЯ ПОЛУЧЕНИЯ ТЕРАПЕВТИЧЕСКИ АКТИВНЫХ СОЕДИНЕНИЙ
DE69815380D1 (de) N,n'-bis (sulfonyl) hydrazine die als antineoplastische mittel nützlich sind
DE69316324D1 (de) 4-Hydroxy-phenyl-beta-D-glukose-monoester, Verfahren zur ihrer Herstellung und ihre Verwendung in der Kosmetik, der Pharmazie, als Zahnpflegemitteln und Lebensmitteln
KR930000527A (ko) 칼슘-길항성 물질로서의 이노시톨 포스페이트 동족체
ATE104313T1 (de) Neue 9-g(a)-hydroxy-3-oxo-4,24(25)-stigmastadien26-s|urederivate,verfahren zur herstellung und heilmittel daraus.
DK0434560T3 (da) Hidtil ukendte substituerede aminosyrederivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
ITMI920082A1 (it) Derivati solforati di acidi biliari
ATE4720T1 (de) Neue derivate von cardenolid-bis-digitoxosiden, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DK0865422T3 (da) Anvendelse af aminoalkoholderivater som lægemidler, hidtil ukendte derivater og fremgangsmåde til fremstilling deraf
ATE186907T1 (de) Optisch aktives 1-phenylpyrrolidonderivat und dessen herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties